Javed Khan

High-throughput Approaches to Uncover Synergistic Drug Combinations in Leukemia

Emma J. Chory, Aleksandra M. Michalowska, J. Bradner, 2022, bioRxiv.

Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib

M. Gottesman, Bao Tran, R. Robey, 2023, bioRxiv.

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

Jun S. Wei, E. Calleja, P. Shinn, 2023, Cancers.

An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma

Mitchell Ho, Jun S. Wei, J. Khan, 2022, The Journal of clinical investigation.

Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours

B. S. Croix, S. Mackay, Jing Zhou, 2023, Nature communications.